Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Low grade serous ovarian carcinoma (LGSOC)

Opening up new horizons through combination therapies

    • RX
    • Congress Reports
    • Gynecology
    • Oncology
    • Studies
  • 17 minute read

This year’s congress of the European Society for Medical Oncology , which took place in Berlin from October 17 to 21, 2025, offered an impressive variety of topics on numerous tumor entities and therapeutic approaches. These were presented in various formats. These included interactive formats such as the “Challenge your Expert” sessions, in which the audience could ask questions, make critical comments and confront the experts with practical challenges. In the “Challenge your Expert-Session-Gynae-Cancers”, David M. Gershenson presented new therapeutic approaches for low-grade serous ovarian cancer (LGSOC). His presentation focused on the development of innovative combination therapies that go beyond the current standards of chemotherapy and hormone therapy and open up new horizons for the treatment of this rare tumor entity.

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten
Already a member? Log in here
Autoren
  • Dr. oec. Odile Schwarz-Herion
Publikation
  • InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
  • BRAF
  • Chemotherapy + Letrozole versus Letrozole
  • Combination therapy
  • Hormonal therapy
  • international Phase II/III study GOG 0281
  • Johns Hopkins study
  • KRAS
  • Low grade serous ovarian carcinoma (LGSOC)
  • Maintenance therapy
  • MAP kinase signaling pathway mutation
  • MD Anderson Cancer Center (MDACC)
  • Mixed tumors LGSOC and HGSOC
  • molecular precision medicine
  • NRAS
Previous Article
  • Rare diseases

Yellow nail and Swyer-James syndrome

  • RX
  • CME continuing education
  • Dermatology and venereology
  • General Internal Medicine
  • Infectiology
  • Pneumology
View Post
Next Article
  • Case Report

6-year-old child with central retinal artery occlusion

  • RX
  • Cases
  • Education
  • Ophthalmology
  • Pediatrics
  • Studies
View Post
You May Also Like
View Post
  • 7 min
  • Obesity: A Multimodal and Interdisciplinary Approach

New Swiss Clinical Practice Guideline Provides Guidance

    • RX
    • Congress Reports
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • Prevention and health care
    • Studies
    • Surgery
View Post
  • 7 min
  • cSCC: Personalizing Treatment Strategies and Follow-up Care Plans

Comprehensive risk stratification is no simple matter: what’s new?

    • RX
    • Congress Reports
    • Dermatology and venereology
    • Oncology
    • Studies
View Post
  • 12 min
  • Baxdrostat – a new class of drugs for treating difficult-to-control hypertension

First Aldosterone Synthase Inhibitor Is Here

    • RX
    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Studies
View Post
  • 3 min
  • Geriatric Small-Cell Lung Cancer

Therapeutic Challenges

    • RX
    • Education
    • Geriatrics
    • Oncology
    • Pneumology
    • Studies
View Post
  • 8 min
  • Chronic Pruritus in Renal, Hepatic, and Biliary Tract Diseases

Pooled Expertise for Targeted Evaluation and Treatment

    • RX
    • Dermatology and venereology
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nephrology
    • Studies
View Post
  • 6 min
  • Advanced Thyroid Cancer

Molecular Mechanisms and New Therapeutic Approaches

    • RX
    • Education
    • Endocrinology and Diabetology
    • Oncology
View Post
  • 4 min
  • Epidermolysis bullosa

Promoting Wound Healing with Gene Therapies and Birch Bark Extract

    • RX
    • Dermatology and venereology
    • Education
    • Genetics
    • Pediatrics
    • Pharmacology and toxicology
    • Phytotherapy
    • Studies
View Post
  • 18 min
  • From Risk Identification to Anti-Inflammatory Intervention

Inflammation as a Treatment Goal in Its Own Right

    • RX
    • Angiology
    • Cardiology
    • CME continuing education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.